TTD | Drug: D0T4XV

Drug General Information
Drug ID	D0T4XV
Former ID	DIB004937
Drug Name	SL-18.1616
Indication	Insomnia [ICD9: 307.41, 307.42, 327.0, 780.51, 780.52; ICD10:F51.0, G47.0]		Terminated	[547238]
Company	Sanofi-Synthelabo
Target and Pathway
Target(s)	Melatonin receptor	Target Info	Agonist	[550889]
KEGG Pathway	Neuroactive ligand-receptor interaction
KEGG Pathway	Circadian entrainment
Reactome	Class A/1 (Rhodopsin-like receptors)
Reactome	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Small Ligand GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 547238	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014349)
Ref 550889	US patent application no. 2005,016,4987, Melatonin combination therapy for improving sleep quality.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information